bullish
Cadila Healthcare: Potential More than 30% Upside.
176 Views22 Nov 2016 04:42
Cadila Healthcare Ltd (CDH IN) is the 4th largest pharmaceutical company in India and 9th largest generic drug company in the U.S. At FY 2018 P/E...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Cipla: Not the Best Among Peers but Catching up Fast, Keep on Watchlist.07 Dec 2016
- Saroglitazar: Targeting Non-Alcoholic Steatohepatitis, a Potential US$35-40 Billion Market.25 Nov 2016
- Aurobindo Pharma: Analysis and Valuation24 Nov 2016
- Cadila Healthcare: Potential More than 30% Upside.22 Nov 2016
- Lupin Ltd.: Another Undervalued Generic Drugs Powerhouse17 Nov 2016
x